NOHA: A Promising Biomarker for Determining Estrogen Receptor Status Among Patients With Breast Cancer in Resource-Constrained Settings

NOHA: A Promising Biomarker for Determining Estrogen Receptor Status Among Patients With Breast Cancer in Resource-Constrained Settings

PURPOSEChallenges to breast cancer control in low-and middle-income countries exist because of constrained access to care, including pathology services. Immunohistochemistry (IHC)–based estrogen receptor (ER) analysis is limited-nonexistent because of few and inadequately staffed and equipped pathol...

Full description

Bibliographic Details
Main Authors: Furaha Serventi, Augustine Musyoka, Jamie Saunders, Alex Mremi, Blandina Theophil Mmbaga, Elizabeth Patrick, Theresia Mwakyembe, Michael Jones, F. Lee. Lucas, Susan Miesfeldt, Srinidi Mohan
Format: Article
Language:English
Published: American Society of Clinical Oncology 2022-12-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO.22.00192

Internet

https://ascopubs.org/doi/10.1200/GO.22.00192

Similar Items